EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Understanding Inflammation and Tissue Damage: Markers of Persistent Sequelae in COVID-19 Patients

Raul Patrascu, Cristina Stefania Dumitru iD

Journal of Clinical Medicine · 22.02.2025 · 14 (5) · 1475

DOI: 10.3390/jcm14051475 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.02.2025. Verfasst von Raul Patrascu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review explores the crucial role of established and emerging biomarkers in the diagnosis, management, and understanding of post-COVID-19 conditions. With COVID-19 affecting multiple organ systems, biomarkers have been instrumental in identifying ongoing inflammation and tissue damage, facilitating early diagnosis and prognostication. Specifically, markers like C-reactive protein (CRP), interleukin-6 (IL-6), and novel entities such as soluble urokinase plasminogen activator receptor (suPAR) and neutrophil extracellular traps (NETs) provide insights into the pathophysiological mechanisms and predict long-term outcomes. This review highlights the integration of these biomarkers into clinical workflows and their implications for personalized medicine, emphasizing their potential in guiding therapeutic interventions and monitoring recovery. Future directions suggest a focus on longitudinal studies to explore biomarker trajectories and their interaction with therapeutic outcomes, aiming to enhance the management of post-COVID-19 conditions and refine public health strategies.

Schlagwörter

Stichwörter der Autor:innen

biomarkersinflammationlong COVIDlongitudinal studiespost-COVID-19 conditionstissue damage

Autor:innen und Institutionen

  • Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
  • Department of Microscopic Morphology/Histology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

ORCID-Profile: Cristina Stefania Dumitru

Förderung

  • VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY TIMISOARA

Zitieren

APA

Patrascu, R., & Dumitru, C. S. (2025). Advances in Understanding Inflammation and Tissue Damage: Markers of Persistent Sequelae in COVID-19 Patients. Journal of Clinical Medicine, 14(5), 1475. https://doi.org/10.3390/jcm14051475

Vancouver

Patrascu R, Dumitru CS. Advances in Understanding Inflammation and Tissue Damage: Markers of Persistent Sequelae in COVID-19 Patients. Journal of Clinical Medicine. 2025;14(5):1475. doi:10.3390/jcm14051475

BibTeX
@article{Patrascu2025,
  author = {Patrascu, Raul and Dumitru, Cristina Stefania},
  title = {Advances in Understanding Inflammation and Tissue Damage: Markers of Persistent Sequelae in COVID-19 Patients},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {5},
  pages = {1475},
  doi = {10.3390/jcm14051475}
}
Kostenlos starten →